Report Summary
Summary
The infection below the level of larynx is said to be lower respiratory tract infection. Many a times, lower respiratory tract infection is called pneumonia. These infection are not defined uniformly, but epidemiologically, these infections includes flu, bronchitis, bronchiolitis, and pneumonia.
The global lower respiratory tract infection market is anticipated to witness lucrative growth due to increasing prevalence of lung diseases, surge in geriatric population, rise in risk of pneumonia in children, etc. According to World Health Organization (WHO), Respiratory syncytial virus (RSV) is responsible for 30 million lower respiratory tract infection cases in children worldwide, the prevalence of such viral diseases will drive the growth of the global market through 2027.
The drug segment is anticipated to hold the largest share of the global market, in terms of revenue owing to factors like quicker onset of action, faster response, high potency and better efficiency etc. On the basis of transmission, the global market is divided into hospital acquired, ventilator acquired and community acquired. The hospital acquired segment is anticipated to hold the share of the global market due to increase in nosocomial infection owing to MDR (multiple drug resistance) microorganism infection in the hospitals.
Based on the end user, the global lower respiratory tract infection market is segmented into hospitals and clinics, and ambulatory surgical centers. Hospitals are expected to hold the maximum share of the global market since advance facilities from diagnosis to treatment are provided under a roof.
In 2020, the global Lower Respiratory Tract Infection Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2027, with a CAGR of xx% between 2021 and 2027.
This report studies the Lower Respiratory Tract Infection Treatment market size by players, regions, product types and end industries, history data 2017-2020 and forecast data 2021-2027; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
This report focuses on the global top players, covered
Sanofi Pasteur
Merck
GlaxoSmithKline
Pfizer
AstraZeneca
...
Market segment by Regions/Countries, this report covers
North America
Europe
China
Rest of Asia Pacific
Central & South America
Middle East & Africa
Market segment by Type, the product can be split into
Supportive Care
Hospital Care
Drugs
Vaccines
Market segment by Application, the market can be split into
Hospitals
Clinics
Ambulatory Surgical Centers
The study objectives of this report are:
To study and forecast the market size of Lower Respiratory Tract Infection Treatment in global market.
To analyze the global key players, SWOT analysis, value and global market share for top players.
To define, describe and forecast the market by type, end use and region.
To analyze and compare the market status and forecast among global major regions.
To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Lower Respiratory Tract Infection Treatment are as follows:
History Year: 2017-2020
Base Year: 2020
Estimated Year: 2020
Forecast Year 2021 to 2027
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Raw material suppliers
Distributors/traders/wholesalers/suppliers
Regulatory bodies, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade associations and industry bodies
End-use industries
Available Customizations
With the given market data, EternityInsights offers customizations according to the company's specific needs. The following customization options are available for the report:
Further breakdown of Lower Respiratory Tract Infection Treatment market on basis of the key contributing countries.
Detailed analysis and profiling of additional market players.
Table Of Contents
Table of Contents
Lower Respiratory Tract Infection Treatment Market Report by Company, Regions, Types and Applications, Global Status and Forecast to 2025
1 Industry Overview of Lower Respiratory Tract Infection Treatment
1.1 Lower Respiratory Tract Infection Treatment Market Overview
1.1.1 Lower Respiratory Tract Infection Treatment Product Scope
1.1.2 Market Status and Outlook
1.2 Global Lower Respiratory Tract Infection Treatment Market Size and Analysis by Regions
1.2.1 North America
1.2.2 Europe
1.2.3 China
1.2.4 Rest of Asia Pacific
1.2.5 Central & South America
1.2.6 Middle East & Africa
1.3 Lower Respiratory Tract Infection Treatment Market by Type
1.3.1 Supportive Care
1.3.2 Hospital Care
1.3.3 Drugs
1.3.4 Vaccines
1.4 Lower Respiratory Tract Infection Treatment Market by End Users/Application
1.4.1 Hospitals
1.4.2 Clinics
1.4.3 Ambulatory Surgical Centers
2 Global Lower Respiratory Tract Infection Treatment Competition Analysis by Players
2.1 Lower Respiratory Tract Infection Treatment Market Size (Value) by Players (2019 and 2020)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 Company (Top Players) Profiles
3.1 Sanofi Pasteur
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Lower Respiratory Tract Infection Treatment Revenue (Value) (2017-2020)
3.1.5 Recent Developments
3.2 Merck
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Lower Respiratory Tract Infection Treatment Revenue (Value) (2017-2020)
3.2.5 Recent Developments
3.3 GlaxoSmithKline
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Lower Respiratory Tract Infection Treatment Revenue (Value) (2017-2020)
3.3.5 Recent Developments
3.4 Pfizer
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Lower Respiratory Tract Infection Treatment Revenue (Value) (2017-2020)
3.4.5 Recent Developments
3.5 AstraZeneca
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Lower Respiratory Tract Infection Treatment Revenue (Value) (2017-2020)
3.5.5 Recent Developments
4 Global Lower Respiratory Tract Infection Treatment Market Size by Type and Application (2017-2020)
4.1 Global Lower Respiratory Tract Infection Treatment Market Size by Type (2017-2020)
4.2 Global Lower Respiratory Tract Infection Treatment Market Size by Application (2017-2020)
4.3 Potential Application of Lower Respiratory Tract Infection Treatment in Future
4.4 Top Consumer/End Users of Lower Respiratory Tract Infection Treatment
5 North America Lower Respiratory Tract Infection Treatment Development Status and Outlook
5.1 North America Lower Respiratory Tract Infection Treatment Market Size (2017-2020)
5.2 North America Lower Respiratory Tract Infection Treatment Market Size and Market Share by Players (2019 and 2020)
6 Europe Lower Respiratory Tract Infection Treatment Development Status and Outlook
6.1 Europe Lower Respiratory Tract Infection Treatment Market Size (2017-2020)
6.2 Europe Lower Respiratory Tract Infection Treatment Market Size and Market Share by Players (2019 and 2020)
7 China Lower Respiratory Tract Infection Treatment Development Status and Outlook
7.1 China Lower Respiratory Tract Infection Treatment Market Size (2017-2020)
7.2 China Lower Respiratory Tract Infection Treatment Market Size and Market Share by Players (2019 and 2020)
8 Rest of Asia Pacific Lower Respiratory Tract Infection Treatment Development Status and Outlook
8.1 Rest of Asia Pacific Lower Respiratory Tract Infection Treatment Market Size (2017-2020)
8.2 Rest of Asia Pacific Lower Respiratory Tract Infection Treatment Market Size and Market Share by Players (2019 and 2020)
9 Central & South America Lower Respiratory Tract Infection Treatment Development Status and Outlook
9.1 Central & South America Lower Respiratory Tract Infection Treatment Market Size (2017-2020)
9.2 Central & South America Lower Respiratory Tract Infection Treatment Market Size and Market Share by Players (2019 and 2020)
10 Middle East & Africa Lower Respiratory Tract Infection Treatment Development Status and Outlook
10.1 Middle East & Africa Lower Respiratory Tract Infection Treatment Market Size (2017-2020)
10.2 Middle East & Africa Lower Respiratory Tract Infection Treatment Market Size and Market Share by Players (2019 and 2020)
11 Market Forecast by Regions, Type and Application (2021-2027)
11.1 Global Lower Respiratory Tract Infection Treatment Market Size (Value) by Regions (2021-2027)
11.1.1 North America Lower Respiratory Tract Infection Treatment Revenue and Growth Rate (2021-2027)
11.1.2 Europe Lower Respiratory Tract Infection Treatment Revenue and Growth Rate (2021-2027)
11.1.3 China Lower Respiratory Tract Infection Treatment Revenue and Growth Rate (2021-2027)
11.1.4 Rest of Asia Pacific Lower Respiratory Tract Infection Treatment Revenue and Growth Rate (2021-2027)
11.1.5 Central & South America Lower Respiratory Tract Infection Treatment Revenue and Growth Rate (2021-2027)
11.1.6 Middle East & Africa Lower Respiratory Tract Infection Treatment Revenue and Growth Rate (2021-2027)
11.2 Global Lower Respiratory Tract Infection Treatment Market Size (Value) by Type (2021-2027)
11.3 Global Lower Respiratory Tract Infection Treatment Market Size by Application (2021-2027)
12 Lower Respiratory Tract Infection Treatment Market Dynamics
12.1 Lower Respiratory Tract Infection Treatment Market Opportunities
12.2 Lower Respiratory Tract Infection Treatment Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Lower Respiratory Tract Infection Treatment Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Lower Respiratory Tract Infection Treatment Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 Research Finding/Conclusion
15 Appendix
Methodology
Analyst Introduction
Data Source
